$0.0425
-0.274[-86.57%]
Last update: 11:37AM Get Real Time Here
Evelo Biosciences
(OTCPK:EVLO)Evelo Biosciences Stock (OTC:EVLO), Analyst Ratings, Price Targets, Predictions
Evelo Biosciences Inc has a consensus price target of $15.83, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from TD Cowen, Morgan Stanley, and Morgan Stanley on October 18, 2023, July 26, 2023, and February 15, 2023. With an average price target of $4 between TD Cowen, Morgan Stanley, and Morgan Stanley, there's an implied 7900.00% upside for Evelo Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Morgan Stanley
Chardan Capital
JMP Securities
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Evelo Biosciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/18/2023 | EVLO | Buy Now | Evelo Biosciences | $0.05 | — | TD Cowen | Joseph Thome | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/26/2023 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 19900% | Morgan Stanley | Vikram Purohit | $2 → $10 | Maintains | Equal-Weight | Get Alert |
| 02/15/2023 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 3900% | Morgan Stanley | Vikram Purohit | $80 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/16/2022 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 4900% | Chardan Capital | Keay Nakae | → $50 | Downgrade | Buy → Neutral | Get Alert |
| 09/09/2022 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 7900% | Morgan Stanley | Vikram Purohit | $100 → $80 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 9900% | Morgan Stanley | Vikram Purohit | $120 → $100 | Maintains | Equal-Weight | Get Alert |
| 08/15/2022 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 9900% | Chardan Capital | Keay Nakae | $240 → $100 | Maintains | Buy | Get Alert |
| 11/02/2021 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 82900% | JMP Securities | Gobind Singh | — | Maintains | Market Outperform | Get Alert |
| 11/01/2021 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 23900% | Chardan Capital | Keay Nakae | — | Upgrade | Neutral → Buy | Get Alert |
| 06/23/2021 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 75900% | JMP Securities | Gobind Singh | — | Maintains | Market Outperform | Get Alert |
| 06/23/2021 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 55900% | Cantor Fitzgerald | Kristen Kluska | — | Initiates | → Overweight | Get Alert |
| 05/03/2021 | EVLO | Buy Now | Evelo Biosciences | $0.05 | 25900% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Evelo Biosciences (EVLO)?
The latest price target for Evelo Biosciences (OTCPK: EVLO) was reported by TD Cowen on October 18, 2023. The analyst firm set a price target for $0.00 expecting EVLO to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Evelo Biosciences (EVLO)?
The latest analyst rating for Evelo Biosciences (OTCPK: EVLO) was provided by TD Cowen, and Evelo Biosciences downgraded their market perform rating.
When was the last upgrade for Evelo Biosciences (EVLO)?
The last upgrade for Evelo Biosciences Inc happened on November 1, 2021 when Chardan Capital raised their price target to $12. Chardan Capital previously had a neutral for Evelo Biosciences Inc.
When was the last downgrade for Evelo Biosciences (EVLO)?
The last downgrade for Evelo Biosciences Inc happened on October 18, 2023 when TD Cowen changed their price target from N/A to N/A for Evelo Biosciences Inc.
When is the next analyst rating going to be posted or updated for Evelo Biosciences (EVLO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evelo Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evelo Biosciences was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
Is the Analyst Rating Evelo Biosciences (EVLO) correct?
While ratings are subjective and will change, the latest Evelo Biosciences (EVLO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Evelo Biosciences (EVLO) is trading at is $0.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.